Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer
The DOI matches its Crossref record; 125 of the 126 references it cites were found in a registry or an index.
Abstract
First described over 80 years ago, ataxia-telangiectasia (A-T) was defined as a clinical entity 50 years ago. Although not encountered by most clinicians, it is a paradigm for cancer predisposition and neurodegenerative disorders and has a central role in our understanding of the DNA-damage response, signal transduction and cell-cycle control. The discovery of the protein A-T mutated (ATM) that is deficient in A-T paved the way for rapid progress on understanding how ATM functions with a host of other proteins to protect against genome instability and reduce the risk of cancer and other pathologies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“p53 (TP53), which is a major target of the PI3K-related protein kinases (PI3K) ATM and ATR and that plays a pivotal role in DDR 5”
From Senescence from G2 arrest, revisited (2015) · cites this paper as [5]
In the citing paper
“ATM is a defective gene in Ataxia-telangiectasia (A-T), an autosomal recessive disorder with early onset progressive cerebellar ataxia, oculocutaneous telangiectasia, and lymphoid tumor susceptibility [48, 49].”
From Functional interplay between ATM/ATR-mediated DNA damage response and DNA repair pathways in oxidative stress (2014) · cites this paper as [48]
Citations
Cites
DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation
Bakkenist, C. J., & Kastan, M. B. (2003) · Nature · doi:10.1038/nature01368 · Cited by 3,466 · cited 1×
“Indeed, chloroquine and other agents that alter chromatin structure can cause partial activation of ATM in the absence of DNA DSB”
BackgroundATM and ATR Substrate Analysis Reveals Extensive Protein Networks Responsive to DNA Damage
Matsuoka, S., Ballif, B. A., Smogorzewska, A., McDonald, E. R., Hurov, K. E., Luo, J., Bakalarski, C. E., Zhao, Z., Solimini, N., Lerenthal, Y., et al. (2007) · Science · doi:10.1126/science.1140321 · Cited by 3,075 · cited 1×
“ATM has multiple substrates — indeed, recent proteomic analysis of phosphoproteins induced by DNA damage suggest that the ATM and ATR network might have as many as 700 substrate”
BackgroundKastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047 · cited 1×
“This was not surprising, because the stabilization and activation of p53 was defective in A-T cells, and these cells were also characterized by a defective G1–S checkpoint, in which p53 has a central rol”
BackgroundA Single Ataxia Telangiectasia Gene with a Product Similar to PI-3 Kinase
Savitsky, K., Bar-Shira, A., Gilad, S., Rotman, G., Ziv, Y., Vanagaite, L., Tagle, D. A., Smith, S., Uziel, T., Sfez, S., et al. (1995) · Science · doi:10.1126/science.7792600 · Cited by 2,785
Self-citationActivation of the ATM Kinase by Ionizing Radiation and Phosphorylation of p53
Canman, C. E., Lim, D.-S., Cimprich, K. A., Taya, Y., Tamai, K., Sakaguchi, K., Appella, E., Kastan, M. B., & Siliciano, J. D. (1998) · Science · doi:10.1126/science.281.5383.1677 · Cited by 2,042
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions
Gorgoulis, V. G., Vassiliou, L.-V. F., Karakaidos, P., Zacharatos, P., Kotsinas, A., Liloglou, T., Venere, M., DiTullio, R. A., Kastrinakis, N. G., Levy, B., et al. (2005) · Nature · doi:10.1038/nature03485 · Cited by 2,009
Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints
Bartkova, J., Rezaei, N., Liontos, M., Karakaidos, P., Kletsas, D., Issaeva, N., Vassiliou, L.-V. F., Kolettas, E., Niforou, K., Zoumpourlis, V. C., et al. (2006) · Nature · doi:10.1038/nature05268 · Cited by 1,986
An Oncogene-Induced DNA Damage Model for Cancer Development
Halazonetis, T. D., Gorgoulis, V. G., & Bartek, J. (2008) · Science · doi:10.1126/science.1140735 · Cited by 1,851 · cited 1×
“DNA breaks per se can also be beneficial in that they activate a DNA-damage response in pre-cancerous cells, thereby establishing a barrier to tumour progressio”
BackgroundATR: an essential regulator of genome integrity
Cimprich, K. A., & Cortez, D. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2450 · Cited by 1,798
Enhanced Phosphorylation of p53 by ATM in Response to DNA Damage
Banin, S., Moyal, L., Shieh, S.-Y., Taya, Y., Anderson, C. W., Chessa, L., Smorodinsky, N. I., Prives, C., Reiss, Y., Shiloh, Y., et al. (1998) · Science · doi:10.1126/science.281.5383.1674 · Cited by 1,797
Research works printed but not linked: 2
- Syllaba, K. & Henner, K. Contribution a l'independence de l'athetose double idiopathique et congenitale. Atteinte familiale, syndrome dystrophique, signe de reseau vasculaire conjonctival, integrite psychique. Rev. Neurol. 1, 541–562 (1926) (in French).
- Digweed, M., Reis, A. & Sperling, K. Nijmegen breakage syndrome: consequences of defective DNA double strand break repair. Bioessays 21, 649–656 (1999). · doi:10.1002/(sici)1521-1878(199908)21:8<649::aid-bies4>3.0.co;2-o
Cited by
Items 401–500 of 898
Metabolic Stress and Mitochondrial Dysfunction in Ataxia-Telangiectasia
Subramanian, G. N., Yeo, A. J., Gatei, M. H., Coman, D. J., & Lavin, M. F. (2022) · Antioxidants · doi:10.3390/antiox11040653 · Cited by 29
Self-citationPatra, T., Meyer, K., Ray, R. B., & Ray, R. (2019) · Hepatology · doi:10.1002/hep.30893 · Cited by 26
Updated risk factors to inform early pancreatic cancer screening and identify high risk patients
Principe, D. R., & Rana, A. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.04.022 · Cited by 29
Update on the management of the immunodeficiency in ataxia-telangiectasia
Davies, E. G. (2009) · Expert Review of Clinical Immunology · doi:10.1586/eci.09.35 · Cited by 27
Differential function of NBS1 and ATR in neurogenesis
Zhou, Z., Bruhn, C., & Wang, Z. (2011) · DNA repair · doi:10.1016/j.dnarep.2011.10.021 · Cited by 26
Huynh, J. M., & Laukaitis, C. M. (2016) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.197 · Cited by 25
Specchia, V., Puricella, A., D’Attis, S., Massari, S., Giangrande, A., & Bozzetti, M. P. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00010 · Cited by 26
Lozinski, M., Bowden, N. A., Graves, M. C., Fay, M. F., & Tooney, P. A. (2021) · Cellular Oncology · doi:10.1007/s13402-021-00613-0 · Cited by 32
“ATM is activated and recruited at the site of DSBs via the Mre11-Rad50-Nbs1 (MRN) complex, leading to the phosphorylation of substrates such as Brac1, H2AX, Chk2 and p53, which mediate the downstream effect of DNA repair and cell-cycle arrest in the G1/S phase [40].”
miR-151-5p, targeting chromatin remodeler SMARCA5, as a marker for the BRCAness phenotype
Tommasi, S., Pinto, R., Danza, K., Pilato, B., Palumbo, O., Micale, L., & Summa, S. D. (2016) · Oncotarget · doi:10.18632/oncotarget.10345 · Cited by 25
Joshi, M., Grivas, P. D., Mortazavi, A., Monk, P., Clinton, S. K., Woo, M. S., Holder, S. L., Drabick, J. J., & Yin, M. (2020) · Cancer Medicine · doi:10.1002/cam4.3552 · Cited by 27
Feliubadaló, L., Moles‐Fernández, A., Santamariña, M., Sánchez, A. T., López‐Novo, A., Porras, L.-M., Blanco, A., Capellá, G., de la Hoya, M., Molina, I. J., et al. (2020) · Clinical Chemistry · doi:10.1093/clinchem/hvaa250 · Cited by 29
Juncker, M. A., Kim, C., Reed, R. E., Haas, A. L., Schwartzenburg, J., & Desai, S. D. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166102 · Cited by 27
A Role for Vascular Deficiency in Retinal Pathology in a Mouse Model of Ataxia-Telangiectasia
Raz-Prag, D., Galron, R., Segev‐Amzaleg, N., Solomon, A., Shiloh, Y., Barzilai, A., & Frenkel, D. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.05.026 · Cited by 24
Zent, C. S., & Burack, R. (2014) · Hematology · doi:10.1182/asheducation-2014.1.119 · Cited by 26
DNA double-strand break repair, immunodeficiency and the RIDDLE syndrome
Blundred, R., & Stewart, G. S. (2011) · Expert Review of Clinical Immunology · doi:10.1586/eci.10.93 · Cited by 25
Histone Deacetylase Inhibitor: Antineoplastic Agent and Radiation Modulator
Konsoula, Z., Velena, A., Lee, R., Dritschilo, A., & Jung, M. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0254-1_14 · Cited by 27
Cell-free Xenopus egg extracts for studying DNA damage response pathways
Cupello, S., Richardson, C. A., & Yan, S. (2016) · The International Journal of Developmental Biology · doi:10.1387/ijdb.160113sy · Cited by 25
Molecular and Functional Characterization of a Cohort of Spanish Patients with Ataxia-Telangiectasia
Carranza, D., Vega, A. K., Torres‐Rusillo, S., Montero-Mateos, E., Martínez-González, L. J., Santamaria, M. L., Santos, J. L., & Molina, I. J. (2016) · NeuroMolecular Medicine · doi:10.1007/s12017-016-8440-8 · Cited by 24
Clinically Applicable Inhibitors Impacting Genome Stability
Prakash, A., García-Moreno, J. F., Brown, J. A. L., & Bourke, E. (2018) · Molecules · doi:10.3390/molecules23051166 · Cited by 26
Shao, L., Feng, W., Lee, K. J., Chen, B. P. C., & Zhou, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033499 · Cited by 30
Marzano, V., Santini, S., Rossi, C., Zucchelli, M., D’Alessandro, A., Marchetti, C., Mingardi, M., Stagni, V., Barilà, D., & Urbani, A. (2012) · Journal of Proteomics · doi:10.1016/j.jprot.2012.05.029 · Cited by 23
In vivo effects of dexamethasone on blood gene expression in ataxia telangiectasia
Menotta, M., Biagiotti, S., Orazi, S., Rossi, L., Chessa, L., Leuzzi, V., D’Agnano, D., Plebani, A., Soresina, A., & Magnani, M. (2017) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-017-3122-x · Cited by 23
Motor pathway degeneration in young ataxia telangiectasia patients: A diffusion tractography study
Sahama, I., Sinclair, K., Fiori, S., Doecke, J. D., Pannek, K., Reid, L. B., Lavin, M. F., & Rose, S. (2015) · NeuroImage Clinical · doi:10.1016/j.nicl.2015.08.007 · Cited by 24
Self-citationCameron, R. S., Liu, C., & Pihkala, J. P. S. (2013) · Cytoskeleton · doi:10.1002/cm.21109 · Cited by 28
Ovarian Cancer: In Search of Better Marker Systems Based on DNA Repair Defects
Varga, D., Deniz, M., Schwentner, L., & Wiesmüller, L. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14010640 · Cited by 24
Characterization of the role of Fhit in suppression of DNA damage
Saldivar, J. C., Bene, J., Hosseini, S. A., Miuma, S., Horton, S., Heerema, N. A., & Huebner, K. (2012) · Advances in Biological Regulation · doi:10.1016/j.jbior.2012.10.003 · Cited by 26
“ATM also acts by phosphorylating multiple targets in response to DSBs (Lavin, 2008).”
Borodkina, A. V., Shatrova, A. N., Deryabin, P. I., Grukova, A. A., Nikolsky, N. N., & Burova, E. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1121326 · Cited by 24
The development of ataxia telangiectasia mutated kinase inhibitors
Andrš, M., Korábečný, J., Nepovimová, E., Jun, D., Hodný, Z., Moravcová, S., Hanzlíková, H., & Kuča, K. (2014) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557514666141013140217 · Cited by 23
Mechanistic Links Between ATM and Histone Methylation Codes During DNA Repair
Xu, Y., Xu, C., & Price, B. D. (2012) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-387665-2.00010-9 · Cited by 27
Meschini, R., Morucci, E., Berni, A., Lopez-Martinez, W., & Palitti, F. (2015) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2015.04.009 · Cited by 25
Emerging Perspectives on DNA Double-strand Breaks in Neurodegenerative Diseases
Zhu, L., Wang, D., Cui, K., Liu, D., & Zhu, L. (2019) · Current Neuropharmacology · doi:10.2174/1570159x17666190726115623 · Cited by 25
Heterotopic Purkinje cells in ataxia‐telangiectasia
Bottini, A. R., Gatti, R. A., Wirenfeldt, M., & Vinters, H. V. (2011) · Neuropathology · doi:10.1111/j.1440-1789.2011.01210.x · Cited by 22
ATM-deficient human neural stem cells as an in vitro model system to study neurodegeneration
Carlessi, L., Poli, E., Filippis, L. D., & Delia, D. (2013) · DNA repair · doi:10.1016/j.dnarep.2013.04.013 · Cited by 23
All Stressed Out Without ATM Kinase
Perry, J. J. P., & Tainer, J. A. (2011) · Science Signaling · doi:10.1126/scisignal.2001961 · Cited by 22
“A-T individuals also have a marked tumorigenesis risk, with increased frequencies for most cancers with lymphomas and leukemias being particularly common (6).”
InfluentialSuzuki, K., Nakashima, M., & Yamashita, S. (2010) · Radiation Research · doi:10.1667/rr2007.1 · Cited by 26
Characteristic Eye Movements in Ataxia-Telangiectasia-Like Disorder: An Explanatory Hypothesis
Federighi, P., Ramat, S., Rosini, F., Pretegiani, E., Federico, A., & Rufa, A. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00596 · Cited by 22
“In ataxia-telangiectasia-like disorder, we consider a double pathogenetic effect that may explain its peculiar saccadic behavior: (1) a developmental anomaly”
Ma, Y. F., Wu, Z. H., Gao, M., & Loor, J. J. (2018) · Journal of Dairy Science · doi:10.3168/jds.2017-13954 · Cited by 24
Hahm, E., Lee, J., Abella, T., & Singh, S. V. (2019) · Molecular Carcinogenesis · doi:10.1002/mc.23104 · Cited by 24
PARP goes the weasel! Emerging role of PARP inhibitors in acute leukemias
Fritz, C. E., Portwood, S. M., Przespolewski, A., & Wang, E. S. (2020) · Blood Reviews · doi:10.1016/j.blre.2020.100696 · Cited by 25
Cho, S., Jeong, E. M., Lee, J.-H., Kim, H.-J., Lim, J., Kim, C.-W., Shin, D., Jeon, J., Choi, K., & Kim, I. G. (2012) · Molecules and Cells · doi:10.1007/s10059-012-2201-9 · Cited by 22
The atm-1 gene is required for genome stability in Caenorhabditis elegans
Jones, M. R., Huang, J. C., Chua, S. Y., Baillie, D. L., & Rose, A. M. (2012) · Molecular Genetics and Genomics · doi:10.1007/s00438-012-0681-0 · Cited by 24
Xu, H., Balakrishnan, K., Malaterre, J., Beasley, M., Yan, Y., Essers, J., Appeldoorn, E., Tomaszewski, J. M., Vazquez, M., Verschoor, S., et al. (2010) · PLoS ONE · doi:10.1371/annotation/12224797-353c-4e9c-92f3-a0de9b527415 · Cited by 23
Self-citationDamasceno, J. D., Nunes, V. S., & Tosi, L. R. O. (2013) · Molecular Microbiology · doi:10.1111/mmi.12418 · Cited by 21
Satsuka, A., Mehta, K. P. M., & Laimins, L. A. (2014) · Journal of Virology · doi:10.1128/jvi.02712-14 · Cited by 23
Uehara, M., Kusaba, T., Ida, T., Nakai, K., Nakata, T., Tomita, A., Uehara-Watanabe, N., Ikeda, K., Kitani, T., YAMASHITA, N., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-61456-7 · Cited by 23
NBS1 interacts with Notch signaling in neuronal homeostasis
Zhou, Z.-W., Kirtay, M., Schneble, N., Yakoub, G., Ding, M., Rüdiger, T., Siniuk, K., Lu, R., Jiang, Y.-N., Li, T.-L., et al. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa716 · Cited by 20
Zhou, Z., Liu, Y., Gao, S., Zhou, M., Qi, F., Ding, N., Zhang, J., Li, R., Wang, J., Shi, J., et al. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166303 · Cited by 21
p53 centrosomal localization diagnoses ataxia-telangiectasia homozygotes and heterozygotes
Prodosmo, A., Amicis, A. D., Nisticò, C., Gabriele, M., Rocco, G. D., Monteonofrio, L., Piane, M., Cundari, E., Chessa, L., & Soddu, S. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67289 · Cited by 21
Agathanggelou, A., Weston, V., Perry, T., Davies, N. J., Skowrońska, A., Payne, D. T., Fossey, J., Oldreive, C., Wei, W., Pratt, G., et al. (2015) · Haematologica · doi:10.3324/haematol.2014.115170 · Cited by 26
Tatewaki, N., Konishi, T., Nakajima, Y., Nishida, M., Saito, M., Eitsuka, T., Sakamaki, T., Ikekawa, N., & Nishida, H. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147570 · Cited by 21
Targeting Homologous Recombination Repair in Cancer
Willers, H., Pfäffle, H. N., & Zou, L. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-384999-1.10007-1 · Cited by 22
Morris, C., Tomimatsu, N., Richard, D. J., Cluet, D., Burma, S., Khanna, K. K., & Jalinot, P. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2562 · Cited by 21
Yamamoto, K., Lee, B. J., Li, C., Dubois, R. L., Hobeika, E., Bhagat, G., & Zha, S. (2015) · Leukemia · doi:10.1038/leu.2015.41 · Cited by 22
Roberts, N. J., & Klein, A. P. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.11.008 · Cited by 22
Ataxia Telangiectasia Mutated (ATM) Inhibition Transforms Human Mammary Gland Epithelial Cells
Mandriota, S. J., Buser, R., Lesne, L., Stouder, C., Favaudon, V., Maechler, P., Béna, F., Clément, V., Rüegg, C., Montesano, R., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.078360 · Cited by 21
Oxygen sensing is impaired in ATM-defective cells
Mongiardi, M. P., Stagni, V., Natoli, M., Giaccari, D., D’Agnano, I., Falchetti, M. L., Barilà, D., & Levi, A. (2011) · Cell Cycle · doi:10.4161/cc.10.24.18663 · Cited by 20
Rybanská, I., Reynolds, T. L., Chou, J., Prakash, M., Jefferson, T., Huso, D. L., Desiderio, S. V., & Franco, S. (2013) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0252-t · Cited by 26
Quantitative Analysis of Cellular Senescence in Culture and In Vivo
Zhao, J., Fuhrmann‐Stroissnigg, H., Gurkar, A. U., Flores, R. R., Dorronsoro, A., Stolz, D. B., Croix, C. M. S., Niedernhofer, L. J., & Robbins, P. D. (2017) · Current Protocols in Cytometry · doi:10.1002/cpcy.16 · Cited by 22
Loss of ATM in Airway Epithelial Cells is Associated with Susceptibility to Oxidative Stress
Yeo, A. J., Fantino, E., Czövek, D., Wainwright, C. E., Sly, P. D., & Lavin, M. F. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201611-2210le · Cited by 20
Self-citationRole of the DNA Damage Response in Human Papillomavirus RNA Splicing and Polyadenylation
Nilsson, K., Wu, C., & Schwartz, S. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061735 · Cited by 22
Reconstitution of the Ataxia-Telangiectasia Cellular Phenotype With Lentiviral Vectors
Carranza, D., Torres‐Rusillo, S., Ceballos-Pérez, G., Blanco-Jimenez, E., Muñoz-López, M., Garcia-Perez, J. L., & Molina, I. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02703 · Cited by 20
“Although several organs are affected, abnormalities in hematopoietic cells play prominent roles in the general context of the disease (1).”
Essential Role of Ubiquitin-Fold Modifier 1 Conjugation in DNA Damage Response
Fang, Z. H., & Pan, Z. (2019) · DNA and Cell Biology · doi:10.1089/dna.2019.4861 · Cited by 20
Duecker, R. P., Baer, P. C., Buecker, A., Huenecke, S., Pfeffermann, L., Modlich, U., Bakhtiar, S., Bader, P., Zielen, S., & Schubert, R. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02785 · Cited by 20
Multiparametric cerebellar imaging and clinical phenotype in childhood ataxia telangiectasia
Dineen, R. A., Raschke, F., McGlashan, H. L., Pszczółkowski, S., Hack, L., Cooper, A. D., Prasad, M., Chow, G., Whitehouse, W. P., & Auer, D. P. (2019) · NeuroImage Clinical · doi:10.1016/j.nicl.2019.102110 · Cited by 26
“Defects in the A-T mutated (ATM) gene lead to absent or defective production of ATM protein kinase with roles in repair of double-stranded DNA breaks and regulating cellular responses to oxidative stress (Lavin, 2008; Ditch and Paull, 2012; Chen et al., 2003).”
Molecular Logic Underlying Chromosomal Translocations, Random or Non-Random?
Lin, C., Yang, L., & Rosenfeld, M. G. (2012) · Advances in cancer research · doi:10.1016/b978-0-12-394280-7.00015-4 · Cited by 25
van den Brand, M., Flucke, U. E., Bult, P., Weemaes, C. M. R., & van Deuren, M. (2011) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33831 · Cited by 21
“Chromosome instability syndromes are well known for their increased cancer risk [Digweed and Sperling, 2004; Lavin, 2008].”
BackgroundAltered mucosal immune response after acute lung injury in a murine model of Ataxia Telangiectasia
Eickmeier, O., Kim, S. Y., Herrmann, E. M., Döring, C., Duecker, R. P., Voss, S., Wehner, S., Hölscher, C., Pietzner, J., Zielen, S., et al. (2014) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-14-93 · Cited by 24
Pilie, P. G., Giuliani, V., Wang, W., McGrail, D. J., Bristow, C. A., Ngoi, N. Y. L., Kyewalabye, K., Wani, K., Le, H., Campbell, E., et al. (2024) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-1763 · Cited by 22
Radiation Sensitivity and Tumor Susceptibility in ATM Phospho-Mutant ATF2 Mice
Li, S., Ezhevsky, S. A., Dewing, A., Cato, M. H., Scortegagna, M., Bhoumik, A., Breitwieser, W., Braddock, D. T., Eroshkin, A. M., Qi, J., et al. (2010) · Genes & Cancer · doi:10.1177/1947601910370700 · Cited by 21
Chromatin modifiers and remodellers in DNA repair and signalling
Jeggo, P. A., Downs, J. A., & Gasser, S. M. (2017) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2016.0279 · Cited by 22
“appropriately orchestrate DSB-induced chromatin changes, helping to explain its more significant role in higher compared to lower organisms [9-15].”
Álvarez-Quilón, A., Terrón-Bautista, J., Delgado‐Sainz, I., Serrano-Benítez, A., Romero‐Granados, R., Martínez‐García, P. M., Jimeno-González, S., Bernal‐Lozano, C., Quintero, C., Garcia‐Quintanilla, L., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14638-w · Cited by 20
Zhu, Y., Mao, C., WU, J., Li, S., Ma, R., Cao, H., Ji, M., Jing, C., & Tang, J. (2014) · Oncology Letters · doi:10.3892/ol.2014.2444 · Cited by 19
“The ataxia telangiectasia mutated (ATM) protein is considered to directly or indirectly regulate the repair of double-strand breaks via cell cycle checkpoint control, and inhibition or absence of ATM increases radiosensitivity, indicating that it is critical for the cellular response to DNA damage (4,5).”
RetractedKirshner, M., Galron, R., Frenkel, D., Mandelbaum, G., Shiloh, Y., Wang, Z., & Barzilai, A. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9643-y · Cited by 20
El-Khatib, M., Geara, F. B., Haddadin, M. J., & Gali‐Muhtasib, H. U. (2010) · Radiation Oncology · doi:10.1186/1748-717x-5-107 · Cited by 19
High-content cytometry and transcriptomic biomarker profiling of human B-cell activation
Hennig, C., Ilginus, C., Boztuǧ, K., Skokowa, J., Maródi, L., Szaflarska, A., Sass, M., Pignata, C., Kılıç, S. Ş., Caragol, I., et al. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.06.047 · Cited by 20
Novel caffeine derivatives with antiproliferative activity
Andrš, M., Muthná, D., Řezáčová, M., Seifrtová, M., Šiman, P., Korábečný, J., Benek, O., Doležal, R., Soukup, O., Jun, D., et al. (2016) · RSC Advances · doi:10.1039/c5ra22889a · Cited by 21
Yang, Z., Ouyang, T., Li, J., Wang, T., Fan, Z., Fan, T., Lin, B., Zhang, J., & Xie, Y. (2019) · Breast Cancer Research and Treatment · doi:10.1007/s10549-018-05124-5 · Cited by 20
Metformin: a cheap and well‐tolerated drug that provides benefits for viral infections
Joven, J., Menéndez, J., Fernández-Sénder, L., Espinel, E., Rull, A., Beltrán‐Debón, R., Rodríguez‐Gallego, E., Riera-Borrull, M., Pedro‐Botet, J., Alonso‐Villaverde, C., et al. (2012) · HIV Medicine · doi:10.1111/hiv.12000 · Cited by 18
Park, J., Jo, Y. H., Cho, C. H., Choe, W., Kang, I., Baik, H. H., & Yoon, K. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.11.040 · Cited by 18
Gamper, A. M., Choi, S., Matsumoto, Y., Banerjee, D., Tomkinson, A. E., & Bakkenist, C. J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.352310 · Cited by 24
Jiang, W., Lee, B. J., Li, C., Dubois, R. L., Gostissa, M., Alt, F. W., & Zha, S. (2015) · Blood · doi:10.1182/blood-2015-01-622621 · Cited by 18
Park, S., Kang, J. M., Kim, S. J., Kim, H., Hong, S., Lee, Y. J., & Kim, S. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1687-z · Cited by 21
Cellular‐signaling pathways unveil the carcinogenic potential of chemicals
Hendriks, G., van de Water, B., Schoonen, W. G. E. J., & Vrieling, H. (2013) · Journal of Applied Toxicology · doi:10.1002/jat.2845 · Cited by 20
“…protein 1), SMC-1 (Structural Maintenance of chromosomes 1), gH2AX variant (H2A histone family, member X), the tumor suppressor protein BRCA1 (Breast Cancer 1) and 53BP1 (53 Binding Protein 1) to promote repair of the DNA double-strand breaks (Fernandez-Capetillo et al., 2004; Lavin, 2008).”
An update on pathobiologic roles of anti-glycan antibodies in Guillain-Barré syndrome
Sheikh, K. A., & Zhang, G. (2010) · F1000 Biology Reports · doi:10.3410/b2-21 · Cited by 19
Chloroquine increases phosphorylation of AMPK and Akt in myotubes
Spears, L. D., Tran, A. V., Qin, C. Y., Hobbs, S. B., Burns, C. A. L., Royer, N. K., Zhang, Z., Ralston, L., & Fisher, J. S. (2016) · Heliyon · doi:10.1016/j.heliyon.2016.e00083 · Cited by 20
Dysfunction of cerebellar microglia in Ataxia‐telangiectasia
Levi, H., Bar, E., Cohen‐Adiv, S., Sweitat, S., Kanner, S., Galron, R., Mitiagin, Y., & Barzilai, A. (2021) · Glia · doi:10.1002/glia.24122 · Cited by 19
Abramowicz, I., Carpenter, G., Alfieri, M., Colnaghi, R., Outwin, E. A., Parent, P., Thauvin‐Robinet, C., Iaconis, D., Franco, B., & O’Driscoll, M. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw364 · Cited by 20
Ovchinnikov, D. A., Withey, S., Leeson, H. C., Lei, B. U. W., Sundarrajan, A., Junday, K., Pewarchuk, M. E., Yeo, A. J., Kijas, A. W., Lavin, M. F., et al. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa023 · Cited by 18
Self-citationThe spectrum of ATM gene mutations in Iranian patients with ataxia‐telangiectasia
Amirifar, P., Ranjouri, M. R., Pashangzadeh, S., Lavin, M. F., Yazdani, R., Shad, T. M., Mehrmohamadi, M., Salami, F., Delavari, S., Moamer, S., et al. (2021) · Pediatric Allergy and Immunology · doi:10.1111/pai.13461 · Cited by 20
Self-citationAn anaplerotic approach to correct the mitochondrial dysfunction in ataxia-telangiectasia (A-T)
Yeo, A. J., Subramanian, G. N., Chong, K. L., Gatei, M. H., Parton, R. G., Coman, D. J., & Lavin, M. F. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101354 · Cited by 18
Self-citationDNA Damage Response Inhibitors in Cholangiocarcinoma: Current Progress and Perspectives
Geyik, Ö. G., Anichini, G., Ulukaya, E., Marra, F., & Raggi, C. (2022) · Cells · doi:10.3390/cells11091463 · Cited by 19
Role for Rif1 in the checkpoint response to damaged DNA in Xenopus egg extracts
Kumar, S., Yoo, H. Y., Kumagai, A., Shevchenko, A., Shevchenko, A., & Dunphy, W. G. (2012) · Cell Cycle · doi:10.4161/cc.11.6.19636 · Cited by 18
DeWire, M. D., Beltran, C. J., Boop, F. A., Helton, K. J., Ellison, D. W., McKinnon, P. J., Gajjar, A. J., & Panandiker, A. S. P. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.40.1430 · Cited by 17
Association of ATM Gene Polymorphism with PTC Metastasis in Female Patients
Gu, Y., Liu, X., Yu, Y., Shi, J., Ai, L., Sun, H., Kanu, J. S., Wang, C., & Liu, Y. (2014) · International Journal of Endocrinology · doi:10.1155/2014/370825 · Cited by 17
Ramírez-Lugo, J. S., Yoo, H. Y., Yoon, S. J., & Dunphy, W. G. (2011) · Cell Cycle · doi:10.4161/cc.10.3.14711 · Cited by 21
Crespan, E., Garbelli, A., Amoroso, A., & Maga, G. (2011) · Molecules · doi:10.3390/molecules16097994 · Cited by 17
Hemizygosity for Atm and Brca1 influence the balance between cell transformation and apoptosis
Su, F., Smilenov, L. B., Ludwig, T., Zhou, L., Zhu, J., Zhou, G., & Hall, E. J. (2010) · Radiation Oncology · doi:10.1186/1748-717x-5-15 · Cited by 17
The Mef/Elf4 Transcription Factor Fine Tunes the DNA Damage Response
Sashida, G., Bae, N., Giandomenico, S. D., Asai, T., Gurvich, N., Bazzoli, E., Liu, Y., Huang, G., Zhao, X., Menéndez, S., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0455 · Cited by 17
Suh, K. J., Ryu, H. S., Lee, K.-H., Kim, H., Min, A., Kim, T., Yang, Y., Moon, H., Han, S., Oh, D., et al. (2016) · Breast Cancer Research and Treatment · doi:10.1007/s10549-016-3869-x · Cited by 17
DNA Damage and Oxidative Stress in Human Disease
Maluf, S. W., Marroni, N. P., Heuser, V. D., & Prá, D. (2013) · BioMed Research International · doi:10.1155/2013/696104 · Cited by 17
Metadata
- Authors
- Lavin, M. F.
- Affiliations
- QIMR Berghofer Medical Research Institute (AU)
- Corresponding author
- Lavin, Martin F.
- ORCID
- Lavin, Martin F.
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2008-10
- Volume
- 9
- Issue
- 10
- Pages
- 759-769
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- OpenAlex
- W2139777089
- Cited by
- 901
- References
- 126
- Citations by year
- 2026: 15 · 2025: 16 · 2024: 17 · 2023: 19 · 2022: 36 · 2021: 43 · 2020: 36 · 2019: 42 · 2018: 26 · 2017: 54 · 2016: 50 · 2015: 45 · 2014: 63 · 2013: 76 · 2012: 90
- FWCI
- 6.70
- Type
- journal article
- Language
- en
- Update notices
- erratum (2008-12-01)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
- Keywords
- ataxia telangiectasia, ATM protein, DNA damage response, genomic instability, cancer susceptibility, neurodegenerative diseases, signal transduction, cell cycle regulation
- MeSH terms
- Animals, Ataxia Telangiectasia, DNA Damage, DNA Repair, DNA-Binding Proteins, Humans, Insulin Resistance, Models, Biological, Mutation, Neoplasms, Nerve Degeneration, Protein Processing, Post-Translational, Signal Transduction, Protein Serine-Threonine Kinases, Cell Cycle Proteins, Genetic Predisposition to Disease, Metabolic Syndrome, Tumor Suppressor Proteins, Mice, Ataxia Telangiectasia Mutated Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.